These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30277862)

  • 61. Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.
    Allanore Y; Distler O; Jagerschmidt A; Illiano S; Ledein L; Boitier E; Agueusop I; Denton CP; Khanna D
    Arthritis Rheumatol; 2018 Oct; 70(10):1634-1643. PubMed ID: 29732731
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.
    Mantero JC; Kishore N; Ziemek J; Stifano G; Zammitti C; Khanna D; Gordon JK; Spiera R; Zhang Y; Simms RW; Lafyatis R
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):146-149. PubMed ID: 30277862
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review.
    Fernández-Lázaro D; Iglesias-Lázaro M; Garrosa E; Rodríguez-García S; Jerves Donoso D; Gutiérrez-Abejón E; Jorge-Finnigan C
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837449
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rilonacept: A Newly Approved Treatment for Recurrent Pericarditis.
    Schwier NC
    Ann Pharmacother; 2022 May; 56(5):572-581. PubMed ID: 34459270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rilonacept for the treatment of recurrent pericarditis.
    Fava AM; Reyaldeen R; Lo Presti S; Goyal A; Akintoye E; Hughes D; Klein AL
    Expert Opin Biol Ther; 2022 Jan; 22(1):7-16. PubMed ID: 34757872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis.
    Wang TKM; Klein AL
    Curr Cardiol Rep; 2022 Jan; 24(1):23-30. PubMed ID: 34993745
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of Rilonacept in Recurrent Pericarditis.
    Presti SL; Elajami TK; Reyaldeen R; Anthony C; Klein AL
    Heart Int; 2021; 15(1):20-25. PubMed ID: 36277322
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.